Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Greater Cannabis CO Inc (OP: GCAN )

0.0005 UNCHANGED
Streaming Delayed Price Updated: 2:43 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,050
Open 0.0004
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0005
Today's Range 0.0004 - 0.0005
52wk Range 0.0004 - 0.0013
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Prenatal Cannabis Exposure Not Linked To Elevated Risk Of Autism And Oklahoma Court Rules Pregnant Moms Who Use It Are Not Breaking The Law
Maternal marijuana use is not related to an increased risk of autism spectrum disorder (ASD) in children who were exposed to cannabis in utero. That's according to newly published data in Autism... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Can Marijuana Treat Autism, OCD & Irritable Bowel Syndrome? Ohio Medical Panel Will Investigate
Ohio researchers want to learn more about the effects of medical marijuana on those with autism spectrum disorder (ASD), obsessive-compulsive disorder (OCD) and irritable bowel syndrome, reported... 
Via Benzinga

Performance

YTD
-37.50%
-37.50%
1 Month
-16.67%
-16.67%
3 Month
-28.57%
-28.57%
6 Month
-16.67%
-16.67%
1 Year
-28.57%
-28.57%

More News

Read More
Cannabinoids & Autism Spectrum Disorder: This Baltimore Company Is On Track To Start Phase 2 Clinical Trial For New Treatment
Via Benzinga
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders
From The Greater Cannabis Company, Inc.
Via GlobeNewswire
Cannabis Movers & Shakers: Coda Signature, Greater Cannabis Co., BioHarvest Sciences, Compass Pathways
Via Benzinga
Topics Cannabis
Exposures Cannabis
Greater Cannabis Partners with Shaare Zedek Scientific on Innovative Neuropsychiatric Cannabinoid Therapy
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.